表紙
市場調查報告書

醫療產業的生態系統:各疾病類型、支付制度、診斷設備、體外診斷技術、流通管道、病床能力、付款者類型、其他、各地區趨勢 - 全球產業分析與預測

Ecosystem of Healthcare Industry Research Report: By Disease Type, Payment Mechanism, Diagnostic Equipment Type, In-vitro Diagnostic Technology, Channel, Hospital Bed Capacity, Payer Type, & Others, Regional Insight - Growth Prospect & Forecast to 2024

出版商 Prescient & Strategic Intelligence Private Limited 商品編碼 888881
出版日期 內容資訊 英文 329 Pages
商品交期: 2-3個工作天內
價格
醫療產業的生態系統:各疾病類型、支付制度、診斷設備、體外診斷技術、流通管道、病床能力、付款者類型、其他、各地區趨勢 - 全球產業分析與預測 Ecosystem of Healthcare Industry Research Report: By Disease Type, Payment Mechanism, Diagnostic Equipment Type, In-vitro Diagnostic Technology, Channel, Hospital Bed Capacity, Payer Type, & Others, Regional Insight - Growth Prospect & Forecast to 2024
出版日期: 2019年05月01日內容資訊: 英文 329 Pages
簡介

本報告提供全球醫療產業的生態系統的調查分析,市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業簡介等相關資訊彙整。

第1章 調查的過程

第2章 調查方法

第3章 摘要整理

第4章 簡介

  • 市場區隔定義
    • 各疾病類型
    • 各支付制度
    • 各診斷設備
    • 各體外診斷技術
    • 各流通管道
    • 各病床能力
    • 各付款者類型
    • 各供應商類型
    • 各照護途徑階段
    • 各病期
  • 市場趨勢
    • 趨勢
    • 促進要素
    • 阻礙要素
  • 波特五力分析
  • 技術進步
  • 法律規章概要
  • 大環境分析
  • 價格分析

第5章 美國市場

第6章 德國市場

第7章 英國市場

第8章 法國市場

第9章 中國市場

第10章 日本市場

第11章 新加坡市場

第12章 競爭趨勢

第13章 企業簡介

第14章 附錄

目錄

Title:
Ecosystem of Healthcare Industry Research Report: By Disease Type, Payment Mechanism, Diagnostic Equipment Type, In-vitro Diagnostic Technology, Channel, Hospital Bed Capacity, Payer Type, Provider Type, Care Pathway Stage, Disease Stage Type, Regional Insight (U.S., U.K, France, Germany, China, Japan, Singapore) - Growth Prospect and Forecast to 2024.

Healthcare Ecosystem Insights is a report that provides an analysis of the healthcare industry in Germany, Singapore, France, Japan, the U.K., China, and the U.S. Growing at a 3.6% CAGR during the forecast period, the healthcare industry of China is projected to reach $542.4 billion by 2024. Government initiatives and improved infrastructure, growing chronic disease prevalence, and increasing healthcare expenditure and gross domestic product are stimulating the industry growth in these countries.

The major categories of the healthcare industry, based on diagnostic equipment type, are ultrasound devices, computed tomography scanners, X-ray, magnetic resonance imaging systems, endoscopes, and mammography equipment. In all the countries covered in the report, X-ray is expected to be the fastest growing category in addition to being the largest. During the forecast period, a 40.4% share in Singapore's healthcare industry is predicted to be occupied by the X-ray category by 2024, progressing at a 6.4% CAGR. The growth of this category is attributed to the increasing use of such systems for various diseases' diagnosis.

The healthcare industry is subdivided into fee-for-service, self-pay, and value-based reimbursement, based on payment mechanism. Fee-for-service is expected to hold a 70.1% share by 2024 in the U.K. healthcare industry, as it is the most commonly used payment mechanism in the country. The increase in the number of people preferring this payment mechanism over others, owing to its provision to pay individually for different services, is predicted to result in this category's growth at an expected 3.0% CAGR during the forecast period.

Based on in-vitro diagnostics (IVD) technology, the categories of the healthcare industry are clinical chemistry, microbiology, immunoassay/immunochemistry, molecular diagnostics, urinalysis, hematology, and others. The largest market share in the French healthcare industry was held by the immunoassay/immunochemistry category, accounting for 43.8%, and it is projected to grow at a 4.2% CAGR during the forecast period. The popularity of this category can be attributed to technological advancements. Additionally, the hematology and molecular diagnostics categories are projected to hold a revenue share of 6.6% and 14.2%, respectively, by 2024.

The fastest growth is expected to be witnessed by the U.S. healthcare industry at a 6.6% CAGR during the forecast period. The rising prevalence of chronic diseases is considered a key factor in the region's growth. About six in 10 adults suffer from a chronic disease, as per the 2019 National Center for Chronic Disease Prevention and Health Promotion report. It is the top fifth country in the world considering the age-standardized rate for all cancers. The increasing cancer prevalence in the country is expected to drive the demand for advanced diagnostic imaging systems, thereby driving the industry growth.

To strengthen their product portfolio and increase their market share, key players in the healthcare industry are acquiring other players. For instance, Core Medical Imaging Inc., a medical imaging product and services company, was acquired by Shimadzu Medical Systems USA in January 2019.

Table of Content

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Disease Type
    • 1.3.2 Market Segmentation by Payment Mechanism
    • 1.3.3 Market Segmentation by Diagnostic Equipment Type
    • 1.3.4 Market Segmentation by In-vitro Diagnostic (IVD) Technology
    • 1.3.5 Market Segmentation by Channel
    • 1.3.6 Market Segmentation by Hospital Bed Capacity
    • 1.3.7 Market Segmentation by Payer Type
    • 1.3.8 Market Segmentation by Provider Type
    • 1.3.9 Market Segmentation by Care Pathway Stage
    • 1.3.10 Market Segmentation by Disease Stage
    • 1.3.11 Market Segmentation by Country
    • 1.3.12 Analysis Period
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By country
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Disease Type
      • 4.1.1.1 Cardiovascular and circulatory diseases
      • 4.1.1.2 Neuropsychiatric disorders
      • 4.1.1.3 CRD
      • 4.1.1.4 Diabetes, blood, and endocrine disorders
      • 4.1.1.5 Cancer
      • 4.1.1.6 Chronic liver diseases
      • 4.1.1.7 Musculoskeletal disorders
      • 4.1.1.8 Others
    • 4.1.2 By Payment Mechanism
      • 4.1.2.1 Fee-for-service
      • 4.1.2.2 Self-pay
      • 4.1.2.3 Value-based reimbursement
    • 4.1.3 By Diagnostic Equipment Type
      • 4.1.3.1 X-Ray
      • 4.1.3.2 MRI
      • 4.1.3.3 Ultrasound
      • 4.1.3.4 CT
      • 4.1.3.5 Mammography
      • 4.1.3.6 Endoscopes
      • 4.1.3.7 Others
    • 4.1.4 By IVD Technology
      • 4.1.4.1 Immunoassay/immunochemistry
      • 4.1.4.2 Clinical chemistry
      • 4.1.4.3 Molecular diagnostics
      • 4.1.4.4 Microbiology
      • 4.1.4.5 Hematology
      • 4.1.4.6 Urinalysis
      • 4.1.4.7 Others
    • 4.1.5 By Channel
      • 4.1.5.1 Non-profit
      • 4.1.5.2 For-profit
      • 4.1.5.3 State/local
      • 4.1.5.4 Others
    • 4.1.6 By Hospital Bed Capacity
      • 4.1.6.1 <100
        • 4.1.6.2 100-199
        • 4.1.6.3 200-499
      • 4.1.6.4 >=500
    • 4.1.7 By Payer Type
      • 4.1.7.1 Medicare
      • 4.1.7.2 Medicaid
      • 4.1.7.3 Private payers
      • 4.1.7.4 Others
    • 4.1.8 By Provider Type
      • 4.1.8.1 Primary care
      • 4.1.8.2 Nursing care
      • 4.1.8.3 Specialty care
        • 4.1.8.3.1 Endocrinology
        • 4.1.8.3.2 Gastroenterology
        • 4.1.8.3.3 Hematology
        • 4.1.8.3.4 Neurology
        • 4.1.8.3.5 Oncology
        • 4.1.8.3.6 Urology
        • 4.1.8.3.7 Cardiology
        • 4.1.8.3.8 Gynecology
        • 4.1.8.3.9 Others
    • 4.1.9 By Care Pathway Stage
      • 4.1.9.1 Primary prevention
      • 4.1.9.2 Early management
      • 4.1.9.3 Treatment
      • 4.1.9.4 Prevention and management of complications
    • 4.1.10 By Disease Stage
      • 4.1.10.1 Chronic
      • 4.1.10.2 Acute
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Increasing number of collaborations and partnerships
      • 4.2.1.2 Rise in number of mergers and acquisitions
      • 4.2.1.3 Increasing number of product launches
      • 4.2.1.4 Integration of biosensors in healthcare industry
      • 4.2.1.5 Integration of artificial intelligence/machine learning
    • 4.2.2 Drivers
      • 4.2.2.1 Increasing prevalence of chronic diseases
      • 4.2.2.2 Government initiatives and better healthcare infrastructure
      • 4.2.2.3 Increasing GDP and healthcare expenditure
      • 4.2.2.4 Rise in the adoption of healthcare insurance
      • 4.2.2.5 Surge in geriatric population
      • 4.2.2.6 Growing demand of IVD tests
      • 4.2.2.7 Digitalization in healthcare industry
      • 4.2.2.8 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 Stringent regulations
      • 4.2.3.2 High cost of development and management of devices
      • 4.2.3.3 Product recalls
      • 4.2.3.4 Impact analysis of restraints on market forecast
  • 4.3 Porter's Five Forces Analysis
  • 4.4 Regulatory Overview of Healthcare Industry
    • 4.4.1 U.S.
      • 4.4.1.1 Regulations for pharmaceutical products
      • 4.4.1.2 Regulations for healthcare insurance
      • 4.4.1.3 Regulations for medical devices
    • 4.4.2 Europe
      • 4.4.2.1 Regulations for pharmaceutical products and medical devices
      • 4.4.2.2 Regulations for healthcare insurance
    • 4.4.3 APAC
      • 4.4.3.1 China
        • 4.4.3.1.1 Regulations for pharmaceutical products and medical devices
        • 4.4.3.1.2 Regulations for healthcare insurance
      • 4.4.3.2 Japan
        • 4.4.3.2.1 Regulations for pharmaceutical products and medical devices
        • 4.4.3.2.2 Regulations for healthcare insurance
  • 4.5 PESTLE Analysis
  • 4.6 Pricing Analysis
    • 4.6.1 X-Ray Imaging Systems
    • 4.6.2 MRI Systems
    • 4.6.3 Ultrasound Systems
    • 4.6.4 CT Scanners
    • 4.6.5 Nuclear Imaging Systems

Chapter 5. U.S. Market Size and Forecast

  • 5.1 By Disease Type
  • 5.2 By Payment Mechanism
  • 5.3 By Diagnostic Equipment Type
  • 5.4 By IVD Technology
  • 5.5 By Channel
  • 5.6 By Hospital Bed Capacity
  • 5.7 By Payer Type
  • 5.8 By Provider Type
    • 5.8.1 Healthcare Industry for Specialty Care, by Disease Type
  • 5.9 By Care Pathway Stage
  • 5.10 By Disease Stage

Chapter 6. Germany Market Size and Forecast

  • 6.1 By Disease Type
  • 6.2 By Payment Mechanism
  • 6.3 By Diagnostic Equipment Type
  • 6.4 By IVD Technology
  • 6.5 By Channel
  • 6.6 By Hospital Bed Capacity
  • 6.7 By Provider Type
    • 6.7.1 Healthcare Industry for Specialty Care, by Disease Type
  • 6.8 By Care Pathway Stage
  • 6.9 By Disease Stage

Chapter 7. U.K. Market Size and Forecast

  • 7.1 By Disease Type
  • 7.2 By Payment Mechanism
  • 7.3 By Diagnostic Equipment Type
  • 7.4 By IVD Technology
  • 7.5 By Channel
  • 7.6 By Hospital Bed Capacity
  • 7.7 By Provider Type
    • 7.7.1 Healthcare Industry for Specialty Care, by Disease Type
  • 7.8 By Care Pathway Stage
  • 7.9 By Disease Stage

Chapter 8. France Market Size and Forecast

  • 8.1 By Disease Type
  • 8.2 By Payment Mechanism
  • 8.3 By Diagnostic Equipment Type
  • 8.4 By IVD Technology
  • 8.5 By Channel
  • 8.6 By Hospital Bed Capacity
  • 8.7 By Provider Type
    • 8.7.1 Healthcare Industry for Specialty Care, by Disease Type
  • 8.8 By Care Pathway Stage
  • 8.9 By Disease Stage

Chapter 9. China Market Size and Forecast

  • 9.1 By Disease Type
  • 9.2 By Payment Mechanism
  • 9.3 By Diagnostic Equipment Type
  • 9.4 By IVD Technology
  • 9.5 By Channel
  • 9.6 By Hospital Bed Capacity
  • 9.7 By Provider Type
    • 9.7.1 Healthcare Industry for Specialty Care, by Disease Type
  • 9.8 By Care Pathway Stage
  • 9.9 By Disease Stage

Chapter 10. Japan Market Size and Forecast

  • 10.1 By Disease Type
  • 10.2 By Payment Mechanism
  • 10.3 By Diagnostic Equipment Type
  • 10.4 By IVD Technology
  • 10.5 By Channel
  • 10.6 By Hospital Bed Capacity
  • 10.7 By Provider Type
    • 10.7.1 Healthcare Industry for Specialty Care, by Disease Type
  • 10.8 By Care Pathway Stage
  • 10.9 By Disease Stage

Chapter 11. Singapore Market Size and Forecast

  • 11.1 By Disease Type
  • 11.2 By Payment Mechanism
  • 11.3 By Diagnostic Equipment Type
  • 11.4 By IVD Technology
  • 11.5 By Channel
  • 11.6 By Hospital Bed Capacity
  • 11.7 By Provider Type
    • 11.7.1 Healthcare Industry for Specialty Care, by Disease Type
  • 11.8 By Care Pathway Stage
  • 11.9 By Disease Stage

Chapter 12. Competitive Landscape

  • 12.1 Market Share Analysis
    • 12.1.1 Diagnostic Imaging Market
    • 12.1.2 IVD Market
  • 12.2 Global Strategic Developments of Key Players
    • 12.2.1 Product Launches and Approvals
    • 12.2.2 Collaborations
    • 12.2.3 Acquisitions

Chapter 13. Company Profiles

  • 13.1 Diagnostic Equipment Players
    • 13.1.1 General Electric Company
      • 13.1.1.1 Business overview
      • 13.1.1.2 Product and service offerings
      • 13.1.1.3 Key financial summary
    • 13.1.2 Koninklijke Philips N.V.
      • 13.1.2.1 Business overview
      • 13.1.2.2 Product and service offerings
      • 13.1.2.3 Key financial summary
    • 13.1.3 Siemens AG
      • 13.1.3.1 Business overview
      • 13.1.3.2 Product and service offerings
      • 13.1.3.3 Key financial summary
    • 13.1.4 Canon Medical Systems Corporation
      • 13.1.4.1 Business overview
      • 13.1.4.2 Product and service offerings
      • 13.1.4.3 Key financial summary
    • 13.1.5 Shimadzu Corporation
      • 13.1.5.1 Business overview
      • 13.1.5.2 Product and service offerings
      • 13.1.5.3 Key financial summary
    • 13.1.6 Carestream Health Inc.
      • 13.1.6.1 Business overview
      • 13.1.6.2 Product and service offerings
    • 13.1.7 Esaote S.p.A.
      • 13.1.7.1 Business overview
      • 13.1.7.2 Product and service offerings
    • 13.1.8 FUJIFILM Holdings Corporation
      • 13.1.8.1 Business overview
      • 13.1.8.2 Product and service offerings
      • 13.1.8.3 Key financial summary
    • 13.1.9 Samsung Electronics Co. Ltd.
      • 13.1.9.1 Business overview
      • 13.1.9.2 Product and service offerings
      • 13.1.9.3 Key financial summary
    • 13.1.10 Hologic Inc.
      • 13.1.10.1 Business overview
      • 13.1.10.2 Product and service offerings
      • 13.1.10.3 Key financial summary
  • 13.2 IVD Players
    • 13.2.1 bioMerieux S.A.
      • 13.2.1.1 Business overview
      • 13.2.1.2 Product and service offerings
      • 13.2.1.3 Key financial summary
    • 13.2.2 Bio-Rad Laboratories Inc.
      • 13.2.2.1 Business overview
      • 13.2.2.2 Product and service offerings
      • 13.2.2.3 Key financial summary
    • 13.2.3 Thermo Fisher Scientific Inc.
      • 13.2.3.1 Business overview
      • 13.2.3.2 Product and service offerings
      • 13.2.3.3 Key financial summary
    • 13.2.4 Becton, Dickinson and Company
      • 13.2.4.1 Business overview
      • 13.2.4.2 Product and service offerings
      • 13.2.4.3 Key financial summary
    • 13.2.5 Danaher Corporation
      • 13.2.5.1 Business overview
      • 13.2.5.2 Product and service offerings
      • 13.2.5.3 Key financial summary
    • 13.2.6 Abbott Laboratories
      • 13.2.6.1 Business overview
      • 13.2.6.2 Product and service offerings
      • 13.2.6.3 Key financial summary
    • 13.2.7 Siemens AG
      • 13.2.7.1 Business overview
      • 13.2.7.2 Product and service offerings
      • 13.2.7.3 Key financial summary
    • 13.2.8 QIAGEN N.V.
      • 13.2.8.1 Business overview
      • 13.2.8.2 Product and service offerings
      • 13.2.8.3 Key financial summary
    • 13.2.9 DiaSorin S.p.A.
      • 13.2.9.1 Business overview
      • 13.2.9.2 Product and Service Offerings
      • 13.2.9.3 Key financial summary
    • 13.2.10 Ortho-Clinical Diagnostics Inc.
      • 13.2.10.1 Business overview
      • 13.2.10.2 Product and service offerings
    • 13.2.11 F. Hoffmann-La Roche Ltd.
      • 13.2.11.1 Business overview
      • 13.2.11.2 Product and service offerings
      • 13.2.11.3 Key financial summary
    • 13.2.12 Agilent Technologies Inc.
      • 13.2.12.1 Business overview
      • 13.2.12.2 Product and service offerings
      • 13.2.12.3 Key financial summary

Chapter 14. Appendix

  • 14.1 Abbreviations
  • 14.2 Sources and References
  • 14.3 Related Reports

LIST OF TABLES

  • TABLE 1: ANALYSIS PERIOD OF THE STUDY
  • TABLE 2: DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 3: RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4: KEY BODIES WITH REGULATORY AUTHORITY OVER HEALTH CARE IN THE U.S.
  • TABLE 5: PRICE RANGE OF SOME MAJORLY USED X-RAY SYSTEMS
  • TABLE 6: PRICE RANGE OF SOME MAJORLY USED MRI SYSTEMS
  • TABLE 7: PRICE RANGE OF SOME MAJORLY USED ULTRASOUND SYSTEMS
  • TABLE 8: PRICE RANGE OF SOME MAJORLY USED CT SCANNERS
  • TABLE 9: PRICE RANGE OF SOME MAJORLY USED NUCLEAR IMAGING SYSTEMS
  • TABLE 10: U.S. HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2014-2018)
  • TABLE 11: U.S. HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2019-2024)
  • TABLE 12: U.S. HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2014-2018)
  • TABLE 13: U.S. HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2019-2024)
  • TABLE 14: U.S. HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2014-2018)
  • TABLE 15: U.S. HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2019-2024)
  • TABLE 16: U.S. HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2014-2018)
  • TABLE 17: U.S. HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2019-2024)
  • TABLE 18: U.S. HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2014-2018)
  • TABLE 19: U.S. HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2019-2024)
  • TABLE 20: U.S. HEALTHCARE INDUSTRY, BY CHANNEL, $B (2014-2018)
  • TABLE 21: U.S. HEALTHCARE INDUSTRY, BY CHANNEL, $B (2019-2024)
  • TABLE 22: U.S. HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2014-2018)
  • TABLE 23: U.S. HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2019-2024)
  • TABLE 24: U.S. HEALTHCARE INDUSTRY, BY PAYER TYPE, $B (2014-2018)
  • TABLE 25: U.S. HEALTHCARE INDUSTRY, BY PAYER TYPE, $B (2019-2024)
  • TABLE 26: U.S. HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2014-2018)
  • TABLE 27: U.S. HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2019-2024)
  • TABLE 28: U.S. HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2014-2018)
  • TABLE 29: U.S. HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2019-2024)
  • TABLE 30: U.S. HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2014-2018)
  • TABLE 31: U.S. HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2019-2024)
  • TABLE 32: U.S. HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2014-2018)
  • TABLE 33: U.S. HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2019-2024)
  • TABLE 34: GERMANY HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2014-2018)
  • TABLE 35: GERMANY HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2019-2024)
  • TABLE 36: GERMANY HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2014-2018)
  • TABLE 37: GERMANY HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2019-2024)
  • TABLE 38: GERMANY HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2014-2018)
  • TABLE 39: GERMANY HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2019-2024)
  • TABLE 40: GERMANY HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2014-2018)
  • TABLE 41: GERMANY HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2019-2024)
  • TABLE 42: GERMANY HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2014-2018)
  • TABLE 43: GERMANY HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2019-2024)
  • TABLE 44: GERMANY HEALTHCARE INDUSTRY, BY CHANNEL, $B (2014-2018)
  • TABLE 45: GERMANY HEALTHCARE INDUSTRY, BY CHANNEL, $B (2019-2024)
  • TABLE 46: GERMANY HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2014-2018)
  • TABLE 47: GERMANY HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2019-2024)
  • TABLE 48: GERMANY HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2014-2018)
  • TABLE 49: GERMANY HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2019-2024)
  • TABLE 50: GERMANY HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2014-2018)
  • TABLE 51: GERMANY HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2019-2024)
  • TABLE 52: GERMANY HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2014-2018)
  • TABLE 53: GERMANY HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2019-2024)
  • TABLE 54: GERMANY HEALTHCARE INDUSTRY, BY DISEASE STAGE TYPE, $B (2014-2018)
  • TABLE 55: GERMANY HEALTHCARE INDUSTRY, BY DISEASE STAGE TYPE, $B (2019-2024)
  • TABLE 56: U.K. HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2014-2018)
  • TABLE 57: U.K. HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2019-2024)
  • TABLE 58: U.K. HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2014-2018)
  • TABLE 59: U.K. HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2019-2024)
  • TABLE 60: U.K. HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2014-2018)
  • TABLE 61: U.K. HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2019-2024)
  • TABLE 62: U.K. HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2014-2018)
  • TABLE 63: U.K. HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2019-2024)
  • TABLE 64: U.K. HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2014-2018)
  • TABLE 65: U.K. HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2019-2024)
  • TABLE 66: U.K. HEALTHCARE INDUSTRY, BY CHANNEL, $B (2014-2018)
  • TABLE 67: U.K. HEALTHCARE INDUSTRY, BY CHANNEL, $B (2019-2024)
  • TABLE 68: U.K. HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2014-2018)
  • TABLE 69: U.K. HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2019-2024)
  • TABLE 70: U.K. HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2014-2018)
  • TABLE 71: U.K. HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2019-2024)
  • TABLE 72: U.K. HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2014-2018)
  • TABLE 73: U.K. HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2019-2024)
  • TABLE 74: U.K. HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2014-2018)
  • TABLE 75: U.K. HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2019-2024)
  • TABLE 76: U.K. HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2014-2018)
  • TABLE 77: U.K. HEALTHCARE INDUSTRY, BY DISEASE STAGE TYPE, $B (2019-2024)
  • TABLE 78: FRANCE HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2014-2018)
  • TABLE 79: FRANCE HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2019-2024)
  • TABLE 80: FRANCE HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2014-2018)
  • TABLE 81: FRANCE HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2019-2024)
  • TABLE 82: FRANCE HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2014-2018)
  • TABLE 83: FRANCE HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2019-2024)
  • TABLE 84: FRANCE HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2014-2018)
  • TABLE 85: FRANCE HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2019-2024)
  • TABLE 86: FRANCE HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2014-2018)
  • TABLE 87: FRANCE HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2019-2024)
  • TABLE 88: FRANCE HEALTHCARE INDUSTRY, BY CHANNEL, $B (2014-2018)
  • TABLE 89: FRANCE HEALTHCARE INDUSTRY, BY CHANNEL, $B (2019-2024)
  • TABLE 90: FRANCE HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2014-2018)
  • TABLE 91: FRANCE HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2019-2024)
  • TABLE 92: FRANCE HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2014-2018)
  • TABLE 93: FRANCE HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2019-2024)
  • TABLE 94: FRANCE. HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2014-2018)
  • TABLE 95: FRANCE HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2019-2024)
  • TABLE 96: FRANCE HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2014-2018)
  • TABLE 97: FRANCE HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2019-2024)
  • TABLE 98: FRANCE HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2014-2018)
  • TABLE 99: FRANCE HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2019-2024)
  • TABLE 100: CHINA HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2014-2018)
  • TABLE 101: CHINA HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2019-2024)
  • TABLE 102: CHINA HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2014-2018)
  • TABLE 103: CHINA HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2019-2024)
  • TABLE 104: CHINA HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2014-2018)
  • TABLE 105: CHINA HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2019-2024)
  • TABLE 106: CHINA HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2014-2018)
  • TABLE 107: CHINA HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2014-2018)
  • TABLE 108: CHINA HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2014-2018)
  • TABLE 109: CHINA HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2019-2024)
  • TABLE 110: CHINA HEALTHCARE INDUSTRY, BY CHANNEL, $B (2014-2018)
  • TABLE 111: CHINA HEALTHCARE INDUSTRY, BY CHANNEL, $B (2019-2024)
  • TABLE 112: CHINA HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2014-2018)
  • TABLE 113: CHINA HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2019-2024)
  • TABLE 114: CHINA HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2014-2018)
  • TABLE 115: CHINA HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2019-2024)
  • TABLE 116: CHINA HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2014-2018)
  • TABLE 117: CHINA HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2019-2024)
  • TABLE 118: CHINA HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2014-2018)
  • TABLE 119: CHINA HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2019-2024)
  • TABLE 120: CHINA HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2014-2018)
  • TABLE 121: CHINA HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2019-2024)
  • TABLE 122: JAPAN HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2014-2018)
  • TABLE 123: JAPAN HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2019-2024)
  • TABLE 124: JAPAN HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2014-2018)
  • TABLE 125: JAPAN HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2019-2024)
  • TABLE 126: JAPAN HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2014-2018)
  • TABLE 127: JAPAN HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2019-2024)
  • TABLE 128: JAPAN HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2014-2018)
  • TABLE 129: JAPAN HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2019-2024)
  • TABLE 130: JAPAN HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2014-2018)
  • TABLE 131: JAPAN HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2019-2024)
  • TABLE 132: JAPAN HEALTHCARE INDUSTRY, BY CHANNEL, $B (2014-2018)
  • TABLE 133: JAPAN HEALTHCARE INDUSTRY, BY CHANNEL, $B (2019-2024)
  • TABLE 134: JAPAN HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2014-2018)
  • TABLE 135: JAPAN HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2019-2024)
  • TABLE 136: JAPAN HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2014-2018)
  • TABLE 137: JAPAN HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2019-2024)
  • TABLE 138: JAPAN HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2014-2018)
  • TABLE 139: JAPAN HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2019-2024)
  • TABLE 140: JAPAN HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2014-2018)
  • TABLE 141: JAPAN HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2019-2024)
  • TABLE 142: JAPAN HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2014-2018)
  • TABLE 143: JAPAN HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2019-2024)
  • TABLE 144: SINGAPORE HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2014-2018)
  • TABLE 145: SINGAPORE HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2019-2024)
  • TABLE 146: SINGAPORE HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2014-2018)
  • TABLE 147: SINGAPORE HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2019-2024)
  • TABLE 148: SINGAPORE HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2014-2018)
  • TABLE 149: SINGAPORE HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2019-2024)
  • TABLE 150: SINGAPORE HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2014-2018)
  • TABLE 151: SINGAPORE HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2019-2024)
  • TABLE 152: SINGAPORE HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2014-2018)
  • TABLE 153: SINGAPORE HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2019-2024)
  • TABLE 154: SINGAPORE HEALTHCARE INDUSTRY, BY CHANNEL, $B (2014-2018)
  • TABLE 155: SINGAPORE HEALTHCARE INDUSTRY, BY CHANNEL, $B (2019-2024)
  • TABLE 156: SINGAPORE HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2014-2018)
  • TABLE 157: SINGAPORE HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2019-2024)
  • TABLE 158: SINGAPORE HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2014-2018)
  • TABLE 159: SINGAPORE HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2019-2024)
  • TABLE 160: SINGAPORE HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2014-2018)
  • TABLE 161: SINGAPORE HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2019-2024)
  • TABLE 162: SINGAPORE HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2014-2018)
  • TABLE 163: SINGAPORE HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2019-2024)
  • TABLE 164: SINGAPORE HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2014-2018)
  • TABLE 165: SINGAPORE HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2019-2024)
  • TABLE 166: GENERAL ELECTRIC COMPANY - AT A GLANCE
  • TABLE 167: GENERAL ELECTRIC COMPANY - KEY FINANCIAL SUMMARY
  • TABLE 168: KONINKLIJKE PHILIPS N.V. - AT A GLANCE
  • TABLE 169: KONINKLIJKE PHILIPS N.V. - KEY FINANCIAL SUMMARY
  • TABLE 170: SIEMENS AG - AT A GLANCE
  • TABLE 171: SIEMENS AG - KEY FINANCIAL SUMMARY
  • TABLE 172: CANON MEDICAL SYSTEMS CORPORATION - AT A GLANCE
  • TABLE 173: CANON MEDICAL SYSTEMS CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 174: SHIMADZU CORPORATION - AT A GLANCE
  • TABLE 175: SHIMADZU CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 176: CARESTREAM HEALTH INC. - AT A GLANCE
  • TABLE 177: ESAOTE S.P.A. - AT A GLANCE
  • TABLE 178: FUJIFILM HOLDINGS CORPORATION - AT A GLANCE
  • TABLE 179: FUJIFILM HOLDINGS CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 180: SAMSUNG ELECTRONICS CO. LTD. - AT A GLANCE
  • TABLE 181: SAMSUNG ELECTRONICS CO. LTD. - KEY FINANCIAL SUMMARY
  • TABLE 182: HOLOGIC INC. - AT A GLANCE
  • TABLE 183: HOLOGIC INC. - KEY FINANCIAL SUMMARY
  • TABLE 184: BIOMÉRIEUX S.A. - AT A GLANCE
  • TABLE 185: BIOMÉRIEUX S.A. - KEY FINANCIAL SUMMARY
  • TABLE 186: BIO-RAD LABORATORIES INC. - AT A GLANCE
  • TABLE 187: BIO-RAD LABORATORIES INC. - KEY FINANCIAL SUMMARY
  • TABLE 188: THERMO FISHER SCIENTIFIC INC. - AT A GLANCE
  • TABLE 189: THERMO FISHER SCIENTIFIC INC. - KEY FINANCIAL SUMMARY
  • TABLE 190: BECTON, DICKINSON AND COMPANY - AT A GLANCE
  • TABLE 191: BECTON, DICKINSON AND COMPANY - KEY FINANCIAL SUMMARY
  • TABLE 192: DANAHER CORPORATION - AT A GLANCE
  • TABLE 193: DANAHER CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 194: ABBOTT LABORATORIES - AT A GLANCE
  • TABLE 195: ABBOTT LABORATORIES - KEY FINANCIAL SUMMARY
  • TABLE 196: SIEMENS AG - AT A GLANCE
  • TABLE 197: SIEMENS AG - KEY FINANCIAL SUMMARY
  • TABLE 198: QIAGEN N.V. - AT A GLANCE
  • TABLE 199: QIAGEN N.V. - KEY FINANCIAL SUMMARY
  • TABLE 200: DIASORIN S.P.A. - AT A GLANCE
  • TABLE 201: DIASORIN S.P.A. - KEY FINANCIAL SUMMARY
  • TABLE 202: ORTHO-CLINICAL DIAGNOSTICS INC. - AT A GLANCE
  • TABLE 203: F. HOFFMANN-LA ROCHE LTD. - AT A GLANCE
  • TABLE 204: F. HOFFMANN-LA ROCHE LTD. - KEY FINANCIAL SUMMARY
  • TABLE 205: AGILENT TECHNOLOGIES INC. - AT A GLANCE
  • TABLE 206: AGILENT TECHNOLOGIES INC. - KEY FINANCIAL SUMMARY

LIST OF FIGURES

  • FIG. 1: RESEARCH SCOPE
  • FIG. 2: RESEARCH METHODOLOGY
  • FIG. 3: SPLIT OF PRIMARY AND SECONDARY RESEARCH, BY COUNTRY
  • FIG. 4: BREAKDOWN OF PRIMARY RESEARCH, BY COUNTRY
  • FIG. 5: BREAKDOWN OF PRIMARY RESEARCH, BY INDUSTRY PARTICIPANT
  • FIG. 6: BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
  • FIG. 7: DATA TRIANGULATION APPROACH
  • FIG. 8: EXECUTIVE SUMMARY
  • FIG. 9: GDP OF SOME MAJOR COUNTRIES, $M (2011 & 2017)
  • FIG. 10: HEALTHCARE EXPENDITURE AS PERCENTAGE OF GDP (2011 & 2017)
  • FIG. 11: BARGAINING POWER OF BUYERS
  • FIG. 12: BARGAINING POWER OF SUPPLIERS
  • FIG. 13: INTENSITY OF RIVALRY
  • FIG. 14: THREAT OF NEW ENTRANTS
  • FIG. 15: THREAT OF SUBSTITUTES
  • FIG. 16: PESTLE ANALYSIS FOR THE U.S.
  • FIG. 17: PESTLE ANALYSIS FOR THE U.K.
  • FIG. 18: PESTLE ANALYSIS FOR FRANCE
  • FIG. 19: PESTLE ANALYSIS FOR GERMANY
  • FIG. 20: PESTLE ANALYSIS FOR CHINA
  • FIG. 21: PESTLE ANALYSIS FOR JAPAN
  • FIG. 22: PESTLE ANALYSIS FOR SINGAPORE
  • FIG. 23: U.S. HEALTHCARE INDUSTRY SNAPSHOT
  • FIG. 24: U.S. HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2014-2024)
  • FIG. 25: U.S. HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2014-2024)
  • FIG. 26: U.S. HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2014-2024)
  • FIG. 27: U.S. HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2014-2024)
  • FIG. 28: U.S. HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2014-2024)
  • FIG. 29: U.S. HEALTHCARE INDUSTRY, BY CHANNEL, $B (2014-2024)
  • FIG. 30: U.S. HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2014-2024)
  • FIG. 31: U.S. HEALTHCARE INDUSTRY, BY PAYER TYPE, $B (2014-2024)
  • FIG. 32: U.S. HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2014-2024)
  • FIG. 33: U.S. HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2014-2024)
  • FIG. 34: U.S. HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2014-2024)
  • FIG. 35: U.S. HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2014-2024)
  • FIG. 36: GERMANY HEALTHCARE INDUSTRY SNAPSHOT
  • FIG. 37: GERMANY HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2014-2024)
  • FIG. 38: GERMANY HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2014-2024)
  • FIG. 39: GERMANY HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2014-2024)
  • FIG. 40: GERMANY HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2014-2024)
  • FIG. 41: GERMANY HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2014-2024)
  • FIG. 42: GERMANY HEALTHCARE INDUSTRY, BY CHANNEL, $B (2014-2024)
  • FIG. 43: GERMANY HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2014-2024)
  • FIG. 44: GERMANY HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2014-2024)
  • FIG. 45: GERMANY HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2014-2024)
  • FIG. 46: GERMANY HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2014-2024)
  • FIG. 47: GERMANY HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2014-2024)
  • FIG. 48: U.K. HEALTHCARE INDUSTRY SNAPSHOT
  • FIG. 49: U.K. HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2014-2024)
  • FIG. 50: U.K. HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2014-2024)
  • FIG. 51: U.K. HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2014-2024)
  • FIG. 52: U.K. HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2014-2024)
  • FIG. 53: U.K. HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2014-2024)
  • FIG. 54: U.K. HEALTHCARE INDUSTRY, BY CHANNEL, $B (2014-2024)
  • FIG. 55: U.K. HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2014-2024)
  • FIG. 56: U.K. HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2014-2024)
  • FIG. 57: U.K. HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2014-2024)
  • FIG. 58: U.K. HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2014-2024)
  • FIG. 59: U.K. HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2014-2024)
  • FIG. 60: FRANCE HEALTHCARE INDUSTRY SNAPSHOT
  • FIG. 61: FRANCE HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2014-2024)
  • FIG. 62: FRANCE HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2014-2024)
  • FIG. 63: FRANCE HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2014-2024)
  • FIG. 64: FRANCE HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2014-2024)
  • FIG. 65: FRANCE HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2014-2024)
  • FIG. 66: FRANCE HEALTHCARE INDUSTRY, BY CHANNEL, $B (2014-2024)
  • FIG. 67: FRANCE HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2014-2024)
  • FIG. 68: FRANCE HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2014-2024)
  • FIG. 69: FRANCE HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2014-2024)
  • FIG. 70: FRANCE HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2014-2024)
  • FIG. 71: FRANCE HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2014-2024)
  • FIG. 72: CHINA HEALTHCARE INDUSTRY SNAPSHOT
  • FIG. 73: CHINA HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2014-2024)
  • FIG. 74: CHINA HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2014-2024)
  • FIG. 75: CHINA HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2014-2024)
  • FIG. 76: CHINA HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2014-2024)
  • FIG. 77: CHINA HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2014-2024)
  • FIG. 78: CHINA HEALTHCARE INDUSTRY, BY CHANNEL, $B (2014-2024)
  • FIG. 79: CHINA HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2014-2024)
  • FIG. 80: CHINA HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2014-2024)
  • FIG. 81: CHINA HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2014-2024)
  • FIG. 82: CHINA HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2014-2024)
  • FIG. 83: CHINA HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2014-2024)
  • FIG. 84: JAPAN HEALTHCARE INDUSTRY SNAPSHOT
  • FIG. 85: JAPAN HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2014-2024)
  • FIG. 86: JAPAN HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2014-2024)
  • FIG. 87: JAPAN HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2014-2024)
  • FIG. 88: JAPAN HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2014-2024)
  • FIG. 89: JAPAN HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2014-2024)
  • FIG. 90: JAPAN HEALTHCARE INDUSTRY, BY CHANNEL, $B (2014-2024)
  • FIG. 91: JAPAN HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2014-2024)
  • FIG. 92: JAPAN HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2014-2024)
  • FIG. 93: JAPAN HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2014-2024)
  • FIG. 94: JAPAN HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2014-2024)
  • FIG. 95: JAPAN HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2014-2024)
  • FIG. 96: SINGAPORE HEALTHCARE INDUSTRY SNAPSHOT
  • FIG. 97: SINGAPORE HEALTHCARE INDUSTRY, BY DISEASE TYPE, $M (2014-2024)
  • FIG. 98: SINGAPORE HEALTHCARE INDUSTRY, BY PAYMENT MECHANISM, $B (2014-2024)
  • FIG. 99: SINGAPORE HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, $M (2014-2024)
  • FIG. 100: SINGAPORE HEALTHCARE INDUSTRY, BY DIAGNOSTIC EQUIPMENT TYPE, UNIT (2014-2024)
  • FIG. 101: SINGAPORE HEALTHCARE INDUSTRY, BY IVD TECHNOLOGY, $M (2014-2024)
  • FIG. 102: SINGAPORE HEALTHCARE INDUSTRY, BY CHANNEL, $B (2014-2024)
  • FIG. 103: SINGAPORE HEALTHCARE INDUSTRY, BY HOSPITAL BED CAPACITY, $B (2014-2024)
  • FIG. 104: SINGAPORE HEALTHCARE INDUSTRY, BY PROVIDER TYPE, $B (2014-2024)
  • FIG. 105: SINGAPORE HEALTHCARE INDUSTRY FOR SPECIALTY CARE, BY DISEASE TYPE, $M (2014-2024)
  • FIG. 106: SINGAPORE HEALTHCARE INDUSTRY, BY CARE PATHWAY STAGE, $B (2014-2024)
  • FIG. 107: SINGAPORE HEALTHCARE INDUSTRY, BY DISEASE STAGE, $B (2014-2024)
  • FIG. 108: MARKET SHARE ANALYSIS OF DIAGNOSTIC IMAGING EQUIPMENT IN THE U.S.
  • FIG. 109: MARKET SHARE ANALYSIS OF DIAGNOSTIC IMAGING EQUIPMENT IN GERMANY
  • FIG. 110: MARKET SHARE ANALYSIS OF DIAGNOSTIC IMAGING EQUIPMENT IN CHINA
  • FIG. 111: MARKET SHARE ANALYSIS OF IVD IN THE U.S.
  • FIG. 112: MARKET SHARE ANALYSIS OF IVD IN GERMANY
  • FIG. 113: MARKET SHARE ANALYSIS OF IVD IN CHINA
  • FIG. 114: GENERAL ELECTRIC COMPANY - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG. 115: KONINKLIJKE PHILIPS N.V. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG. 116: SIEMENS AG - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2018)
  • FIG. 117: CANON MEDICAL SYSTEMS CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG. 118: SHIMADZU CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG. 119: FUJIFILM HOLDINGS CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG. 120: SAMSUNG ELECTRONICS CO. LTD. - REVENUE SPLIT BY BUSINESS DIVISION AND GEOGRAPHY (2017)
  • FIG. 121: HOLOGIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG. 122: BIOMÉRIEUX S.A. - REVENUE SPLIT BY APPLICATION AND GEOGRAPHY (2018)
  • FIG. 123: BIO-RAD LABORATORIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG. 124: THERMO FISHER SCIENTIFIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG. 125: BECTON, DICKINSON AND COMPANY - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG. 126: DANAHER CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG. 127: ABBOTT LABORATORIES - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG. 128: SIEMENS AG - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG. 129: QIAGEN N.V. - REVENUE SPLIT BY GEOGRAPHY AND CONSUMER CLASS (2018)
  • FIG. 130: DIASORIN S.P.A. - REVENUE SPLIT BY GEOGRAPHY (2017)
  • FIG. 131: F. HOFFMANN-LA ROCHE LTD. - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2018)
  • FIG. 132: AGILENT TECHNOLOGIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)